Skip to content
Screener

Xtant Medical Holdings XTNT Q1 2025 earnings

Reported May 12, 2025 · After market close

Revenue$32.9MBeat by $1.7M
EPS$0.00Beat by $0.01
Revenue estimate$31.2M
EPS estimate-$0.01

Next report

Nov 10, 2026 (in 2 months)
Revenue estimate$25.5M
EPS estimate-$0.03

Financials

Q1 2025

Income statement

See full
Revenue$32.9M+18.0%
Gross profit$20.2M+17.0%
Operating income$1.1M+131%
Net income$58.0K+101%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$5.4M+17.5%
Total debt$23.0M+24.6%
Total equity$43.9M-8.0%
Total assets$95.8M+2.0%

Cash flow

See full
Operating cash flow$1.3M+122%
CapEx$1.2M+54.1%
Free cash flow$87.0K+101%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$65.36M-57.1%
Enterprise value$82.96M-50.1%
P/S0.5×-1.0×

Profitability

See full
Gross margin58.2%-3.3pp
Operating margin-6.2%-2.0pp
Net margin-9.8%—
FCF margin-7.7%-2.5pp

Returns & leverage

See full
Return on equity-26.2%—
Debt / equity0.5×+0.1×
Current ratio2.3×0.0×

Segments

By product

See full
Orthobiologics$18.1M+17.2%
Spinal Implant$11.2M-10.0%

FAQ

When did Xtant Medical Holdings report Q1 2025 earnings?
Xtant Medical Holdings (XTNT) reported Q1 2025 earnings on May 12, 2025 after market close.
What were Xtant Medical Holdings's Q1 2025 revenue and EPS?
Xtant Medical Holdings reported revenue of $32.9M and eps of $0.00 for Q1 2025.
Did Xtant Medical Holdings beat estimates in Q1 2025?
Revenue beat the consensus estimate of $31.2M by $1.7M. EPS beat the consensus estimate of $-0.01 by $0.01.
How did Xtant Medical Holdings's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 18.0% from $27.9M a year earlier.
Where can I find Xtant Medical Holdings's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001641172-25-009664) and the 10-Q periodic report (0001641172-25-009674) directly on SEC EDGAR. The filing index links above go to sec.gov.